KEGG   PATHWAY: ko04068
Entry
ko04068                     Pathway                                
Name
FoxO signaling pathway
Description
The forkhead box O (FOXO) family of transcription factors regulates the expression of genes in cellular physiological events including apoptosis, cell-cycle control, glucose metabolism, oxidative stress resistance, and longevity. A central regulatory mechanism of FOXO proteins is phosphorylation by the serine-threonine kinase Akt/protein kinase B (Akt/PKB), downstream of phosphatidylinositol 3-kinase (PI3K), in response to insulin or several growth factors. Phosphorylation at three conserved residues results in the export of FOXO proteins from the nucleus to the cytoplasm, thereby decreasing expression of FOXO target genes. In contrast, the stress-activated c-Jun N-terminal kinase (JNK) and the energy sensing AMP-activated protein kinase (AMPK), upon oxidative and nutrient stress stimuli phosphorylate and activate FoxOs. Aside from PKB, JNK and AMPK, FOXOs are regulated by multiple players through several post-translational modifications, including phosphorylation, but also acetylation, methylation and ubiquitylation.
Class
Environmental Information Processing; Signal transduction
Pathway map
ko04068  FoxO signaling pathway
ko04068

Other DBs
GO: 0009267
Orthology
K00922  PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153]
K01084  G6PC; glucose-6-phosphatase [EC:3.1.3.9]
K01110  PTEN; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [EC:3.1.3.16 3.1.3.48 3.1.3.67]
K01596  E4.1.1.32, pckA, PCK; phosphoenolpyruvate carboxykinase (GTP) [EC:4.1.1.32]
K02206  CDK2; cyclin-dependent kinase 2 [EC:2.7.11.22]
K02649  PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K02833  HRAS; GTPase HRas
K03099  SOS; son of sevenless
K03781  katE, CAT, catB, srpA; catalase [EC:1.11.1.6]
K03875  SKP2, FBXL1; F-box and leucine-rich repeat protein 1 (S-phase kinase-associated protein 2)
K04288  S1PR1, EDG1, CD363; sphingosine 1-phosphate receptor 1
K04293  S1PR4, EDG6; sphingosine 1-phosphate receptor 4
K04357  EGF; epidermal growth factor
K04361  EGFR, ERBB1; epidermal growth factor receptor [EC:2.7.10.1]
K04364  GRB2; growth factor receptor-bound protein 2
K04365  BRAF; B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04366  RAF1; RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04368  MAP2K1, MEK1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
K04369  MAP2K2, MEK2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
K04371  ERK, MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04388  TGFBR2; TGF-beta receptor type-2 [EC:2.7.11.30]
K04389  TNFSF6, FASL, CD178; tumor necrosis factor ligand superfamily member 6
K04402  GADD45; growth arrest and DNA-damage-inducible protein
K04411  STK4, MST1; serine/threonine kinase 4
K04440  JNK; mitogen-activated protein kinase 8/9/10 (c-Jun N-terminal kinase) [EC:2.7.11.24]
K04441  P38; p38 MAP kinase [EC:2.7.11.24]
K04456  AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04467  IKBKA, IKKA, CHUK; inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10]
K04468  NLK; nemo like kinase [EC:2.7.11.24]
K04498  EP300, CREBBP, KAT3; E1A/CREB-binding protein [EC:2.3.1.48]
K04501  SMAD4; mothers against decapentaplegic homolog 4
K04503  CCND1; G1/S-specific cyclin-D1
K04526  INS; insulin
K04527  INSR, CD220; insulin receptor [EC:2.7.10.1]
K04564  SOD2; superoxide dismutase, Fe-Mn family [EC:1.15.1.1]
K04603  GRM1; metabotropic glutamate receptor 1
K04674  TGFBR1, ALK5; TGF-beta receptor type-1 [EC:2.7.11.30]
K04685  CDKN2B, P15, INK4B; cyclin-dependent kinase inhibitor 2B
K04692  STAT3; signal transducer and activator of transcription 3
K04721  TNFSF10, TRAIL, CD253; tumor necrosis factor ligand superfamily member 10
K04728  ATM, TEL1; serine-protein kinase ATM [EC:2.7.11.1]
K05072  IL7R, CD127; interleukin 7 receptor
K05087  IGF1R, CD221; insulin-like growth factor 1 receptor [EC:2.7.10.1]
K05405  IL6; interleukin 6
K05443  IL10, CSIF; interleukin 10
K05459  IGF1; insulin-like growth factor 1
K05868  CCNB1; G2/mitotic-specific cyclin-B1
K06276  PDPK1; 3-phosphoinositide dependent protein kinase-1 [EC:2.7.11.1]
K06623  CDKN2D, P19, INK4D; cyclin-dependent kinase inhibitor 2D
K06624  CDKN1B, P27, KIP1; cyclin-dependent kinase inhibitor 1B
K06625  CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
K06631  PLK1; polo-like kinase 1 [EC:2.7.11.21]
K06643  MDM2; E3 ubiquitin-protein ligase Mdm2 [EC:2.3.2.27]
K07187  IRS2; insulin receptor substrate 2
K07191  SLC2A4, GLUT4; MFS transporter, SP family, solute carrier family 2 (facilitated glucose transporter), member 4
K07198  PRKAA, AMPK; 5'-AMP-activated protein kinase, catalytic alpha subunit [EC:2.7.11.31]
K07199  PRKAB; 5'-AMP-activated protein kinase, regulatory beta subunit
K07200  PRKAG; 5'-AMP-activated protein kinase, regulatory gamma subunit
K07201  FOXO1; forkhead box protein O1
K07209  IKBKB, IKKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10]
K07298  STK11, LKB1; serine/threonine-protein kinase 11 [EC:2.7.11.1]
K07827  KRAS, KRAS2; GTPase KRas
K07828  NRAS; GTPase NRas
K08336  ATG12; ubiquitin-like protein ATG12
K08341  GABARAP, ATG8, LC3; GABA(A) receptor-associated protein
K08845  ARAF, ARAF1; A-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K08861  PLK2; polo-like kinase 2 [EC:2.7.11.21]
K08862  PLK3, CNK; polo-like kinase 3 [EC:2.7.11.21]
K08863  PLK4; polo-like kinase 4 [EC:2.7.11.21]
K08960  CSNK1E; casein kinase 1, epsilon [EC:2.7.11.1]
K09385  FOXG; forkhead box protein G
K09408  FOXO3; forkhead box protein O3
K10146  CCNG2; cyclin G2
K10151  CCND2; G1/S-specific cyclin-D2
K10305  FBXO25_32; F-box protein 25/32
K10628  RAG1; V(D)J recombination-activating protein 1 [EC:2.3.2.27]
K10988  RAG2; recombination-activating protein 2
K11411  SIRT1, SIR2L1; NAD-dependent protein deacetylase sirtuin 1 [EC:2.3.1.286]
K11431  SETD7; [histone H3]-lysine4 N-methyltransferase [EC:2.1.1.364]
K11434  PRMT1; type I protein arginine methyltransferase [EC:2.1.1.319]
K11838  USP7, UBP15; ubiquitin carboxyl-terminal hydrolase 7 [EC:3.4.19.12]
K12358  FOXO4; forkhead box protein O4
K13302  SGK1; serum/glucocorticoid-regulated kinase 1 [EC:2.7.11.1]
K13303  SGK2; serum/glucocorticoid-regulated kinase 2 [EC:2.7.11.1]
K13304  SGK3; serum/glucocorticoid-regulated kinase 3 [EC:2.7.11.1]
K13375  TGFB1; transforming growth factor beta-1
K13376  TGFB2; transforming growth factor beta-2
K13377  TGFB3; transforming growth factor beta-3
K15010  HOMER; homer
K15464  BNIP3; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3
K15618  BCL6; B-cell lymphoma 6 protein
K16172  IRS1; insulin receptor substrate 1
K16332  RBL2; retinoblastoma-like protein 2
K16341  BCL2L11, BIM; Bcl-2-like protein 11
K17445  IRS3; insulin receptor substrate 3
K17446  IRS4; insulin receptor substrate 4
K17845  KLF2; krueppel-like factor 2
K17847  FOXO6; forkhead box protein O6
K17848  AGAP2; Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2
K21770  CCNB2; G2/mitotic-specific cyclin-B2
K21771  CCNB3; G2/mitotic-specific cyclin-B3
K23605  SMAD3; mothers against decapentaplegic homolog 3
K27679  DEPP1; protein DEPP1
Compound
C00008  ADP
C00020  AMP
C00025  L-Glutamate
C00031  D-Glucose
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Glauser DA, Schlegel W
  Title
The emerging role of FOXO transcription factors in pancreatic beta cells.
  Journal
J Endocrinol 193:195-207 (2007)
DOI:10.1677/JOE-06-0191
Reference
  Authors
van der Horst A, Burgering BM
  Title
Stressing the role of FoxO proteins in lifespan and disease.
  Journal
Nat Rev Mol Cell Biol 8:440-50 (2007)
DOI:10.1038/nrm2190
Reference
  Authors
Zhang X, Tang N, Hadden TJ, Rishi AK
  Title
Akt, FoxO and regulation of apoptosis.
  Journal
Biochim Biophys Acta 1813:1978-86 (2011)
DOI:10.1016/j.bbamcr.2011.03.010
Reference
  Authors
Eijkelenboom A, Burgering BM
  Title
FOXOs: signalling integrators for homeostasis maintenance.
  Journal
Nat Rev Mol Cell Biol 14:83-97 (2013)
DOI:10.1038/nrm3507
Reference
  Authors
Daitoku H, Fukamizu A
  Title
FOXO transcription factors in the regulatory networks of longevity.
  Journal
J Biochem 141:769-74 (2007)
DOI:10.1093/jb/mvm104
Reference
  Authors
Hedrick SM
  Title
The cunning little vixen: Foxo and the cycle of life and death.
  Journal
Nat Immunol 10:1057-63 (2009)
DOI:10.1038/ni.1784
Reference
  Authors
Coffer PJ, Burgering BM
  Title
Forkhead-box transcription factors and their role in the immune system.
  Journal
Nat Rev Immunol 4:889-99 (2004)
DOI:10.1038/nri1488
Reference
  Authors
Ro SH, Liu D, Yeo H, Paik JH
  Title
FoxOs in neural stem cell fate decision.
  Journal
Arch Biochem Biophys 534:55-63 (2013)
DOI:10.1016/j.abb.2012.07.017
Reference
  Authors
Maiese K, Chong ZZ, Shang YC
  Title
OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins.
  Journal
Trends Mol Med 14:219-27 (2008)
DOI:10.1016/j.molmed.2008.03.002
Reference
  Authors
Hagenbuchner J, Ausserlechner MJ
  Title
Mitochondria and FOXO3: breath or die.
  Journal
Front Physiol 4:147 (2013)
DOI:10.3389/fphys.2013.00147
Reference
  Authors
Maiese K, Chong ZZ, Shang YC
  Title
"Sly as a FOXO": new paths with Forkhead signaling in the brain.
  Journal
Curr Neurovasc Res 4:295-302 (2007)
DOI:10.2174/156720207782446306
Reference
  Authors
Oh HM, Yu CR, Dambuza I, Marrero B, Egwuagu CE
  Title
STAT3 protein interacts with Class O Forkhead transcription factors in the cytoplasm and regulates nuclear/cytoplasmic localization of FoxO1 and FoxO3a proteins in CD4(+) T cells.
  Journal
J Biol Chem 287:30436-43 (2012)
DOI:10.1074/jbc.M112.359661
Reference
  Authors
Huang H, Tindall DJ
  Title
Regulation of FOXO protein stability via ubiquitination and proteasome degradation.
  Journal
Biochim Biophys Acta 1813:1961-4 (2011)
DOI:10.1016/j.bbamcr.2011.01.007
Reference
  Authors
Greer EL, Brunet A
  Title
FOXO transcription factors at the interface between longevity and tumor suppression.
  Journal
Oncogene 24:7410-25 (2005)
DOI:10.1038/sj.onc.1209086
Reference
  Authors
Seoane J, Le HV, Shen L, Anderson SA, Massague J
  Title
Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation.
  Journal
Cell 117:211-23 (2004)
DOI:10.1016/S0092-8674(04)00298-3
Reference
  Authors
Yamagata K, Daitoku H, Takahashi Y, Namiki K, Hisatake K, Kako K, Mukai H, Kasuya Y, Fukamizu A
  Title
Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akt.
  Journal
Mol Cell 32:221-31 (2008)
DOI:10.1016/j.molcel.2008.09.013
Reference
  Authors
van der Horst A, de Vries-Smits AM, Brenkman AB, van Triest MH, van den Broek N, Colland F, Maurice MM, Burgering BM
  Title
FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP.
  Journal
Nat Cell Biol 8:1064-73 (2006)
DOI:10.1038/ncb1469
Reference
  Authors
Zhang Y, Gan B, Liu D, Paik JH
  Title
FoxO family members in cancer.
  Journal
Cancer Biol Ther 12:253-9 (2011)
DOI:10.4161/cbt.12.4.15954
Reference
  Authors
Van Der Heide LP, Hoekman MF, Smidt MP
  Title
The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation.
  Journal
Biochem J 380:297-309 (2004)
DOI:10.1042/BJ20040167
Related
pathway
ko00010  Glycolysis / Gluconeogenesis
ko00020  Citrate cycle (TCA cycle)
ko00190  Oxidative phosphorylation
ko04010  MAPK signaling pathway
ko04110  Cell cycle
ko04120  Ubiquitin mediated proteolysis
ko04140  Autophagy - animal
ko04151  PI3K-Akt signaling pathway
ko04210  Apoptosis
ko04350  TGF-beta signaling pathway
ko04630  JAK-STAT signaling pathway
ko04910  Insulin signaling pathway

DBGET integrated database retrieval system